Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Ruxolitinib in 2022 and beyond: the good, the suboptimal and the failure

Aaron Gerds, MD, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, gives a presentation on the current and future use of ruxolitinib in myeloproliferative neoplasms (MPNs) at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter